CAROL BUDGIN: Open Payments
NPI 1912056482 · EAST CHICAGO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 30 payments from 9 companies in 2025. Trend: 2023 $716 · 2024 $583 · 2025 $597
Food & beverage: $547Long term medical supply or device loan: $51
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $220 |
| SCPHARMACEUTICALS INC. | 4 | $106 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $55 |
| Amgen Inc. | 3 | $54 |
| Baxter Healthcare | 1 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Boston Scientific Corporation | 1 | $34 |
| Novo Nordisk Inc | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: LEQVIO, FUROSCIX, LifeVest, REPATHA, Hillrom - ELI 280, CAMZYOS, WATCHMAN FLX, Wegovy.
Industry payments across IN — which companies pay providers there.
